ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ProPhase Labs's ebitda for the twelve months ending Jun 30, 2026 was -$12.32M. For fiscal 2025 it was -$13.22M. The highest annual figure on record is $28.31M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.22M | – |
| FY2024 | Dec 31, 2024 | -$32.44M | – |
| FY2023 | Dec 31, 2023 | -$15.17M | -153.6% |
| FY2022 | Dec 31, 2022 | $28.31M | +117.2% |
| FY2021 | Dec 31, 2021 | $13.04M | – |
| FY2020 | Dec 31, 2020 | -$1.63M | – |
| FY2019 | Dec 31, 2019 | -$2.84M | – |
| FY2018 | Dec 31, 2018 | -$1.25M | – |
| FY2017 | Dec 31, 2017 | -$3.65M | – |
| FY2016 | Dec 31, 2016 | -$2.23M | – |
| FY2015 | Dec 31, 2015 | -$3.22M | – |
| FY2014 | Dec 31, 2014 | -$7.55M | -1245.8% |
| FY2013 | Dec 31, 2013 | $659.00K | – |
| FY2012 | Dec 31, 2012 | -$846.00K | – |
| FY2011 | Dec 31, 2011 | -$2.38M | – |
| FY2010 | Dec 31, 2010 | -$3.23M | – |
| FY2009 | Dec 31, 2009 | -$3.41M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.02M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.46M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.07M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.88M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.18M | – |
| Q4 FY2024 | Dec 31, 2024 | -$15.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.70M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.03M | -378.1% |
| Q4 FY2023 | Dec 31, 2023 | -$9.34M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.91M | -231.5% |
| Q2 FY2023 | Jun 30, 2023 | -$4.14M | -135.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.17M | -87.5% |
| Q4 FY2022 | Dec 31, 2022 | -$4.16M | -128.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.97M | – |
| Q2 FY2022 | Jun 30, 2022 | $11.78M | – |
| Q1 FY2022 | Mar 31, 2022 | $17.40M | +890.0% |
| Q4 FY2021 | Dec 31, 2021 | $14.87M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.25M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.06M | -1748.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.76M | – |
| Q4 FY2020 | Dec 31, 2020 | -$565.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$564.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $64.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$730.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$370.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$361.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.17M | – |
| Q1 FY2019 | Mar 31, 2019 | -$943.00K | -2345.2% |
| Q4 FY2018 | Dec 31, 2018 | -$310.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$815.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$169.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $42.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$520.00K | -159.8% |
| Q3 FY2017 | Sep 30, 2017 | -$796.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$790.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$422.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $870.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$682.00K | – |
See a number that looks wrong?